Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748668 · ClinicalTrials.gov registry record
Extracorporeal Membrane Oxygenation (ECMO): Blood Cells
A clinical trial, sponsored by Corewell Health West.
- Terminated
- Registry status
- 371
- Enrollment target
NCT02748668 is a clinical trial that was terminated before completion, run by Corewell Health West. The registered enrollment target is 371 participants.
The verdict
NCT02748668 was terminated before completion, sponsored by Corewell Health West.
- TERMINATED
- Registry status
- 371 participants
- Enrollment target
Study Summary
The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.
Interventions
- OTHER Blood specimen collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2015-01-20 |
| Est. Completion | 2023-08-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02748668
The ClinicalTrials.gov registry entry for NCT02748668 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 371 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood specimen collection is the first listed.
NCT02748668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02748668 about?
NCT02748668 is a clinical study titled "Extracorporeal Membrane Oxygenation (ECMO): Blood Cells". The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.
What is the current status of trial NCT02748668?
This trial is currently terminated. The enrollment target is 371 participants. The study started on 2015-01-20. Estimated completion is 2023-08-23.
What interventions are being tested in trial NCT02748668?
The interventions under investigation include: Blood specimen collection (OTHER).
Who is sponsoring clinical trial NCT02748668?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.